Results 171 to 180 of about 211,160 (222)

Fibroblast Growth Factor 23 is a Potential Prognostic Biomarker in Uterine Sarcoma.

open access: yesTechnol Cancer Res Treat
Yang L   +6 more
europepmc   +1 more source

Uterine sarcoma 2008

open access: yesCurrent Oncology Reports, 2008
Uterine sarcomas are a group of rare and usually aggressive soft tissue cancers. They have a wide range of histologic appearances, from myomatous to osteous to stromal. The three major subtypes of uterine sarcomas (listed in decreasing order of incidence) are carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma.
Jeff F, Lin, Brian M, Slomovitz
openaire   +3 more sources

Uterine Sarcoma

Radiology, 1975
Thirty-four cases of uterine sarcoma were studied with regard to their pathologic characteristics and response to treatment. Pathologic features did not always correlate with subsequent course. Combined therapy seems to enhance two-year survival in endometrial stromal sarcoma (ESS), although some patients may have low-grade tumors and hence represent a
R, Belgrad, N, Elbadawi, P, Rubin
openaire   +2 more sources

Uterine sarcomas

Pathology, 2007
A wide variety of sarcomas occur in the uterus but two subtypes - leiomyosarcoma and endometrial stromal sarcoma - account for a majority of those more routinely encountered. Using the 2003 World Health Organization classification, this review focuses on six uterine sarcomas: endometrial stromal sarcoma, undifferentiated endometrial sarcoma ...
Farid, Moinfar   +2 more
openaire   +2 more sources

Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma Using Magnetic Resonance Images: A Literature Review

open access: yesHealthcare, 2019
MRI plays an essential role in patients before treatment for uterine mesenchymal malignancies. Although MRI includes methods such as diffusion-weighted imaging and dynamic contrast-enhanced MRI, the differentiation between uterine myoma and sarcoma ...
Ayako Suzuki   +2 more
exaly   +2 more sources

Sarcomas of the Uterine Cervix

Australian and New Zealand Journal of Obstetrics and Gynaecology, 1989
EDITORIAL COMMENT: Rarely is this journal offered a paper from China, let alone one presenting 8 cases of primary sarcoma of the cervix. Readers will be interested in the presentation, pathology and different modes of treatment in these 8 patients, 5 of whom are long‐term survivors.
Z Y, Weng, B Y, Yang
openaire   +2 more sources

Uterine Sarcomas: Then and Now

American Journal of Roentgenology, 2012
The purpose of this article is to provide an updated review of uterine sarcomas. The traditionally described neoplasms are reviewed as well as several recently characterized entities in terms of their imaging and clinical aspects. We attempt to provide a longitudinal imaging overview, from initial presentation to follow-up.
Shaan H, Shah   +5 more
openaire   +2 more sources

Uterine sarcomas: A review

Gynecologic Oncology, 2010
Uterine sarcomas are rare tumors that account for 3% of uterine cancers. Their histopathologic classification was revised by the World Health Organization (WHO) in 2003. A new staging system has been recently designed by the International Federation of Gynecology and Obstetrics (FIGO).
D'Angelo E, Prat J
openaire   +4 more sources

Staging of uterine sarcomas

Best Practice & Research Clinical Obstetrics & Gynaecology, 2011
Uterine sarcomas comprise leiomyosarcoma, endometrial stromal sarcoma, adenosarcoma, undifferentiated endometrial sarcoma, and their variants. Carcinosarcoma is historically classified as sarcoma, but it is now regarded as a metaplastic carcinoma. Uterine sarcomas are rare, and are traditionally staged in the same way as endometrial carcinoma.
Ngan, HYS, Tse, KY, Crawford, R
openaire   +4 more sources

Home - About - Disclaimer - Privacy